224 related articles for article (PubMed ID: 31402164)
1. Dimethylarginine dimethylaminohydrolase 1 deficiency aggravates monocrotaline-induced pulmonary oxidative stress, pulmonary arterial hypertension and right heart failure in rats.
Wang D; Li H; Weir EK; Xu Y; Xu D; Chen Y
Int J Cardiol; 2019 Nov; 295():14-20. PubMed ID: 31402164
[TBL] [Abstract][Full Text] [Related]
2. Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction.
Xu X; Zhang P; Kwak D; Fassett J; Yue W; Atzler D; Hu X; Liu X; Wang H; Lu Z; Guo H; Schwedhelm E; Böger RH; Chen P; Chen Y
Basic Res Cardiol; 2017 Aug; 112(5):55. PubMed ID: 28819685
[TBL] [Abstract][Full Text] [Related]
3. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
[TBL] [Abstract][Full Text] [Related]
4. Colchicine Depolymerizes Microtubules, Increases Junctophilin-2, and Improves Right Ventricular Function in Experimental Pulmonary Arterial Hypertension.
Prins KW; Tian L; Wu D; Thenappan T; Metzger JM; Archer SL
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28566298
[TBL] [Abstract][Full Text] [Related]
5. Roles of accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, and attenuated nitric oxide synthase activity in endothelial cells for pulmonary hypertension in rats.
Sasaki A; Doi S; Mizutani S; Azuma H
Am J Physiol Lung Cell Mol Physiol; 2007 Jun; 292(6):L1480-7. PubMed ID: 17322279
[TBL] [Abstract][Full Text] [Related]
6. Involvement of asymmetric dimethylarginine and Rho kinase in the vascular remodeling in monocrotaline-induced pulmonary hypertension.
Li XH; Peng J; Tan N; Wu WH; Li TT; Shi RZ; Li YJ
Vascul Pharmacol; 2010; 53(5-6):223-9. PubMed ID: 20840872
[TBL] [Abstract][Full Text] [Related]
7. Cardiomyocyte dimethylarginine dimethylaminohydrolase1 attenuates left-ventricular remodeling after acute myocardial infarction: involvement in oxidative stress and apoptosis.
Hou L; Guo J; Xu F; Weng X; Yue W; Ge J
Basic Res Cardiol; 2018 Jun; 113(4):28. PubMed ID: 29892894
[TBL] [Abstract][Full Text] [Related]
8. Copaiba Oil Attenuates Right Ventricular Remodeling by Decreasing Myocardial Apoptotic Signaling in Monocrotaline-Induced Rats.
Campos-Carraro C; Turck P; de Lima-Seolin BG; Tavares AMV; Dos Santos Lacerda D; Corssac GB; Teixeira RB; Hickmann A; Llesuy S; da Rosa Araujo AS; Belló-Klein A
J Cardiovasc Pharmacol; 2018 Nov; 72(5):214-221. PubMed ID: 30212415
[TBL] [Abstract][Full Text] [Related]
9. Analyses of long non-coding RNA and mRNA profiles in right ventricle myocardium of acute right heart failure in pulmonary arterial hypertension rats.
Cao Y; Yang Y; Wang L; Li L; Zhang J; Gao X; Dai S; Zhang Y; Guo Q; Peng YG; Wang E
Biomed Pharmacother; 2018 Oct; 106():1108-1115. PubMed ID: 30119177
[TBL] [Abstract][Full Text] [Related]
10. Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure.
Suen CM; Chaudhary KR; Deng Y; Jiang B; Stewart DJ
Cardiovasc Res; 2019 Mar; 115(4):788-799. PubMed ID: 30357319
[TBL] [Abstract][Full Text] [Related]
11. Rosuvastatin attenuates monocrotaline-induced pulmonary hypertension via regulation of Akt/eNOS signaling and asymmetric dimethylarginine metabolism.
Pei Y; Ma P; Wang X; Zhang W; Zhang X; Zheng P; Yan L; Xu Q; Dai G
Eur J Pharmacol; 2011 Sep; 666(1-3):165-72. PubMed ID: 21641341
[TBL] [Abstract][Full Text] [Related]
12. Dimethylarginine dimethylaminohydrolase 1 protects PM
Gao J; Lei T; Wang H; Luo K; Wang Y; Cui B; Yu Z; Hu X; Zhang F; Chen Y; Ding W; Lu Z
Part Fibre Toxicol; 2022 Oct; 19(1):64. PubMed ID: 36242005
[TBL] [Abstract][Full Text] [Related]
13. Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension.
Pullamsetti S; Kiss L; Ghofrani HA; Voswinckel R; Haredza P; Klepetko W; Aigner C; Fink L; Muyal JP; Weissmann N; Grimminger F; Seeger W; Schermuly RT
FASEB J; 2005 Jul; 19(9):1175-7. PubMed ID: 15827267
[TBL] [Abstract][Full Text] [Related]
14. Oxymatrine prevents the development of monocrotaline-induced pulmonary hypertension via regulation of the N
Dai G; Li B; Xu Y; Zeng Z; Yang H
Eur J Pharmacol; 2019 Jan; 842():338-344. PubMed ID: 30419238
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of DDAH2 Limits Pulmonary Hypertension and Right Ventricular Hypertrophy During Chronic Hypoxia in
Hannemann J; Glatzel A; Hillig J; Zummack J; Schumacher U; Lüneburg N; Harbaum L; Böger R
Front Physiol; 2020; 11():597559. PubMed ID: 33281630
[No Abstract] [Full Text] [Related]
16. Impact of dietary iron restriction on the development of monocrotaline-induced pulmonary vascular remodeling and right ventricular failure in rats.
Naito Y; Hosokawa M; Hao H; Sawada H; Hirotani S; Iwasaku T; Okuhara Y; Eguchi A; Hirota S; Ohyanagi M; Tsujino T; Masuyama T
Biochem Biophys Res Commun; 2013 Jun; 436(2):145-51. PubMed ID: 23707944
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of dimethylarginine dimethylaminohydrolase 1 protects from angiotensin II-induced cardiac hypertrophy and vascular remodeling.
Kopaliani I; Jarzebska N; Billoff S; Kolouschek A; Martens-Lobenhoffer J; Bornstein SR; Bode-Böger SM; Ragavan VN; Weiss N; Mangoni AA; Deussen A; Rodionov RN
Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H825-H838. PubMed ID: 34533401
[TBL] [Abstract][Full Text] [Related]
18. Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.
Lambert M; Boet A; Rucker-Martin C; Mendes-Ferreira P; Capuano V; Hatem S; Adão R; Brás-Silva C; Hautefort A; Michel JB; Dorfmuller P; Fadel E; Kotsimbos T; Price L; Jourdon P; Montani D; Humbert M; Perros F; Antigny F
Cardiovasc Res; 2018 May; 114(6):880-893. PubMed ID: 29360952
[TBL] [Abstract][Full Text] [Related]
19. Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
da Silva Gonçalves Bós D; Van Der Bruggen CEE; Kurakula K; Sun XQ; Casali KR; Casali AG; Rol N; Szulcek R; Dos Remedios C; Guignabert C; Tu L; Dorfmüller P; Humbert M; Wijnker PJM; Kuster DWD; van der Velden J; Goumans MJ; Bogaard HJ; Vonk-Noordegraaf A; de Man FS; Handoko ML
Circulation; 2018 Feb; 137(9):910-924. PubMed ID: 29167228
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructural Changes of the Right Ventricular Myocytes in Pulmonary Arterial Hypertension.
Shults NV; Kanovka SS; Ten Eyck JE; Rybka V; Suzuki YJ
J Am Heart Assoc; 2019 Mar; 8(5):e011227. PubMed ID: 30807241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
